Charleston, SC -- (SBWIRE) -- 10/04/2013 -- ImpressivePennyStocks.com covers several stocks on the NASDAQ and New York Stock Exchange that technically qualify as penny stocks, we typically find ones that are on the OTC Market. ImpressivePennyStocks.com issues a special report on the following stocks: Quicksilver Resources Inc (NYSE:KWK), Galena Biopharma Inc (NASDAQ:GALE), McEwen Mining Inc (NYSE:MUX), Idera Pharmaceuticals Inc (NASDAQ:IDRA).
Quicksilver Resources Inc (NYSE:KWK) opened its last trade at the price of $2.33. Its closing price was $2.35 after gaining 1.29% for the day. The company traded with the total volume of 3.30 million shares, while its average trading volume remained 3.03 million shares. The beta of this stock stands at 1.77. Quicksilver Resources Inc. (Quicksilver) is an independent oil and gas company engaged primarily in the acquisition, exploration, development and production of onshore oil and gas in North America. The Company focuses primarily on unconventional reservoirs.
For How Long KWK will Fight for Profitability? Read This Trend Analysis report
Galena Biopharma Inc (NASDAQ:GALE) percentage change surged 4.37% to close at $2.39 with the total traded volume of 8.73 million shares, along with average volume of 3.41 million shares. The 52 week range of the stock remained $1.23 - $3.00, while its day lowest price was $2.30. The share price hit the day highest price of $2.58. Galena Biopharma, Inc. (Galena), formerly RXi Pharmaceuticals Corporation, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics.
For How Long GALE’s Gloss will Attract Investors? Find out via this report
McEwen Mining Inc (NYSE:MUX) traded on volume of 2.17 million shares in the last session against average volume of 4.50 million shares. The company started its trading session with the price of $2.43 and closed at $2.40. McEwen Mining Inc. (McEwen Mining), formerly US Gold Corporation, is engaged in the exploration for and production of precious metals in the United States, Mexico and Argentina. McEwen Mining’s operating segments include USA and Mexico.
How Should Investors Trade MUX Now? Don’t Miss out a Special Trend Analysis
Idera Pharmaceuticals Inc (NASDAQ:IDRA) started its last trading session with the price of $2.00 and closed at $2.45 by scoring 24.37%. The stock traded with total volume of 5.11 million shares, while the average trading volume remained 860,996.00 shares. The beta value of this stock stands at 1.93. Day range for the stock was $2.00 - $2.55. Idera Pharmaceuticals, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of novel synthetic deoxyribonucleic acid (DNA) - and ribonucleic acid (RNA) - based drug candidates. The Company is developing drug candidates that are designed to modulate immune responses mediated through Toll-like Receptors (TLRs).
Why Should Investors Buy IDRA After The Recent Gain? Just Go Here and Find Out
About Impressive Penny Stocks
We are different here at Impressive Penny Stocks because we care about our subscribers. You can email us any time with questions, tips, or just to say hello. We are real people and we love to hear from our loyal subscribers.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the ImpressivePennyStocks.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
ImpressivePennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ImpressivePennyStocks’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by ImpressivePennyStocks or an offer or solicitation to buy or sell any security. Neither the owner of ImpressivePennyStocks nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. ImpressivePennyStocks makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.
Read Full Disclaimer at: http://impressivepennystocks.com/disclaimer/#navigation
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)